Tricentis Founder Wolfgang Platz Releases Book, Enterprise Continuous Testing
Tricentis announced the publication of Enterprise Continuous Testing: Transforming Testing for Agile and DevOps, written by Tricentis Founder Wolfgang Platz and Cynthia Dunlop. This book is targeted to senior quality managers and business executives who need to achieve the optimal balance between speed and quality when delivering the software that drives the modern business. It provides a roadmap for how to accelerate delivery with high confidence and low business risk.
“Even with the most extreme automation, the ‘test everything’ approach is not feasible…but actually, it’s not necessary or even desirable,” explained Wolfgang Platz. “If you rethink your approach to testing, you can get a thorough assessment of a release candidate’s business risk with much less testing than you’re probably performing today.”
Enterprise Continuous Testing: Transforming Testing for Agile and DevOps introduces a Continuous Testing strategy that helps enterprises transform testing to meet the needs of fast-paced Agile and DevOps initiatives. Software testing has traditionally been the enemy of speed and innovation—a slow, costly process that delays releases while delivering questionable business value. This new strategy helps organizations test smarter, so testing provides rapid insight into what matters most to the business.
All Profits to Benefit Specialisterne Austria, a Non-Profit Committed to Inclusion through Neurodiversity
Tricentis is donating all proceeds from Enterprise Continuous Testing to Specialisterne Austria, a non-profit committed to identifying, qualifying, and enabling the employability of talent in the autism spectrum. Under the umbrella of the globally-active Specialisterne Foundation, they partner with corporations, training, and educational institutions to unlock the full potential of neurodiversity for innovation and business excellence.
People with an autism spectrum condition are often great software testers because of their structured and analytical approach, detail-orientation, and perseverance. They quickly identify patterns and tend to find aberrations and mistakes that others miss. Yet, despite these strengths, between 60-80% of adults with autism are unemployed. Specialisterne has made it their mission to change that. Tricentis has been partnering with Specialisterne Austria since 2018 to provide state-of-the-art Software Tester Training for these talented individuals who are otherwise easily overlooked.
“The exceptional involvement of Wolfgang Platz and his team allows our candidates to acquire sought-after testing skills that build on their individual strengths and meet market needs,” explained Markus Kalbhenn, Member of the Managing Board of Specialisterne Austria. “The quality of this training has been instrumental to the incredible success of this program. We are very honored to have Tricentis as our partner and to see this joint commitment strengthened yet again.”
Book Publication Details
- Print copies can be purchased from Amazon.com, Amazon.de, and other Amazon marketplaces.
- Kindle versions can also be purchased from the same Amazon marketplaces. For the remainder of this week, digital copies are priced at 1.99 USD or EUR.
- The PDF can be downloaded for free from the Tricentis Enterprise Continuous Testing site.
About Wolfgang Platz
Wolfgang Platz is the Founder and Chief Product Officer of Tricentis. Wolfgang is the force behind innovations such as model-based automation and the linear expansion test design methodology. The technology he developed drives Tricentis’ Continuous Testing Platform, which is recognized as the industry’s #1 solution by all top analysts. Today, he is responsible for advancing Tricentis’ vision to make resilient enterprise automation a reality across Global 2000 organizations.
Prior to Tricentis, Wolfgang was at Capgemini as a group head of IT development for one of the world’s largest IT insurance-development projects. There, he was responsible for architecture and implementation of life insurance policies and project management for several projects in banks.
Wolfgang holds a Master’s degree in Technical Physics as well as a Master’s degree in Business Administration from the Vienna University of Technology.
With the industry’s #1 Continuous Testing platform, Tricentis is recognized for reinventing software testing for DevOps. Through agile test management and advanced test automation optimized to support 150+ technologies, we provide automated insight into the business risks of your software releases—transforming testing from a roadblock to a catalyst for innovation. The result is accelerated software delivery speed, improved cost efficiency, and reduced business risk.
Tricentis is the only vendor to achieve “leader” status in all three top analyst reports (i.e., the “Triple Crown.”) This honor is based on our technical leadership, innovation, and a Global 2000 customer base of 1600+ companies, including global enterprises such as Allianz, ANZ Bank, Cisco, Dolby, Experian, First Data, HSBC, Merck, Office Depot, Samsung, Swiss Re, Starbucks, Telstra, UBS, Vodafone, Whole Foods, and WorldPay. Customers rely on Tricentis to achieve and sustain test automation rates of over 90 percent—increasing risk coverage while accelerating testing to keep pace with Agile and DevOps.
Tricentis has a global presence in Austria, Australia, Belgium, Denmark, Germany, India, Netherlands, Singapore, Switzerland, Poland, United States and the UK. To learn more, visit https://www.tricentis.com or follow us on LinkedIn, Twitter, and Facebook.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HighRes Biosolutions and Novo Nordisk partner to transform drug discovery in automated Lab of the Future24.1.2020 17:00:00 EET | Press release
HighRes Biosolutions and Novo Nordisk A/S today announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integration of a multi-system robotics platform with sophisticated software control architecture will enable a digital transformation and accelerated discovery for Novo Nordisk’s peptide and large molecule therapeutics research. “In order to maintain our leadership within biologics engineering we are investing in a fully automated and digital design platform. This investment is linked to our build-up in AI and advanced analytics and demonstrates Novo Nordisk’s commitment as a world leading biologics research company,” said Lars Fogh Iversen, senior vice president, Global Research Technologies, Novo Nordisk. The platform will comprise several highly automated and integrated cells for production, characterisation and functional analysis of thousands of biologic compounds every month. Its scop
Conquest Invests in 5 Greenfield Onshore Wind Parks Totalizing 43MW in the Flanders Region24.1.2020 15:37:00 EET | Press release
Conquest, acting through the Conquest Sustainable Infrastructure fund, announced the transaction was closed after an exclusive agreement had been reached with ENGIE Electrabel. Conquest acquires 51% of a portfolio expected to provide 111 GWh per annum of renewable power representing the annual electricity consumption of about 32,000 Belgian homes from early 2021 onwards. The projects benefit from 15 to 20-year green certificates local remuneration schemes, and thus generate yearly secured revenues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005221/en/ Credit: Electrabel While the energy and digital transitions continue to drive the infrastructure sector, Conquest keeps building its diversified sustainable real asset portfolio in Western European markets. The success lies in years of collaboration and long-lasting partnerships with fellow industry experts who can notably facilitate access to new growth opportunities
Fluence Expands EMEA Footprint with Horticulture Partners in Papenburg, Germany24.1.2020 14:00:00 EET | Press release
Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and agriculture production, announced today it is expanding its presence in the Emsland region of Germany through partnerships with growers and other horticulture specialists operating out of Papenburg. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005109/en/ Friedrich Schulz’s 5.5 hectare farm—which grows herbs year-round in addition to lettuce, peppers and chives—utilizing VYPR 2p fixtures. (Photo: Business Wire) Given Papenburg’s decades-long history of attracting horticulture experts, Fluence’s innovative lighting solutions for horticulture are a natural fit for the region’s tomato, cucumber, leafy greens and herb growers. Forging connections with Papenburg’s horticultural leaders Elektro Evers, an engineering firm specializing in greenhouse technology, is Fluence’s exclusive systems integrator
HCL Technologies Honors Global Goodwill Champions at the 2020 World Economic Forum in Davos24.1.2020 12:47:00 EET | Press release
HCL Technologies (HCL), a leading global technology company, today presented its Wave Maker Awards 2020, commemorating global goodwill champions from around the world. The award ceremony, which was held at the HCL Pavilion in Davos, celebrated organizations and individuals passionately committed to such noble causes as diversity & inclusion, education & community upliftment, environment & sustainability, and technology for change. Special guest at the awards was Australian cricket legend Glenn McGrath, who is also founder of the McGrath Foundation, which provides support for Australian women diagnosed with breast cancer and their families. The award recipients were; Lois Auta, Founder and Executive Director of Cedar Seed Foundation, which supports persons with disabilities to participate in all aspects of life; Chido Govera, Founder and Director of The Future of Hope Foundation (TFoHF), which supports marginal and vulnerable members of society through entrepreneurial and self-developme
Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria24.1.2020 09:00:00 EET | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy and safety of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), as well as the ongoing Phase II (PVO-1A-202/204) extension studies. In both the Phase III and Phase II extension studies, palovarotene is dosed both chronically (daily) and episodically (during flare-ups). The decision to pause dosing patients in the trial is based on results of a futility analysis reviewed by the Independent Data Monitoring Committee (IDMC) as part of the prespecified interim analysis. The results of a futility analysis indicated that the Phase III FOP trial was unlikely to meet its primary efficacy endpoint (annualized change in new HO volume as compared with Natural History Studyi) upon completion. Despite the results of the prespecified interim analysis, signals of encouraging therapeutic activity w
Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos23.1.2020 23:56:00 EET | Press release
Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally -- according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty five than younger than five for the first time -- it is imperative for consumers to take proactive measures to maintain a high quality of life, for as long as they live. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200123005820/en/ (Photo: Business Wire) Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom